ストックスクリーナーアプリを入手
5.97
1.36%
0.08
Champions Oncology Inc (CSBR) 最新ニュース
Leading Companies Enhancing Their Presence in the Tumor Models Market - openPR.com
Patient-Derived Xenograft (PDX) Models Market (2026-2033) | - openPR.com
Champions Oncology (NASDAQ:CSBR) Shares Cross Below 200-Day Moving AverageWhat's Next? - MarketBeat
Liquidity Mapping Around (CSBR) Price Events - Stock Traders Daily
Champions Onc (CSBR) Stock: Is It Forming a Pattern (Market Focus) 2026-04-27Social Flow Trades - Newser
Champions Oncology (CSBR) Proxy Filing Summary - Quartr
Champions Oncology (NASDAQ:CSBR) Share Price Passes Below Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Radiopharmaceuticals Market Size to Exceed USD 15.21 Billion By 2035 Rising Cancer Cases Boost the Market Demand - Dailyhunt
Data4Cure Presents a Foundation Model for Forward and Reverse Translation at AACR 2026 Annual Meeting - Scott Coop
Elisrasib Demonstrates High DCR in KRAS G12C+ NSCLC - The ASCO Post
Champions Onc (CSBR) Stock: Growth vs Risks (-0.98%) 2026-04-18Reversal Signals - Xã Vĩnh Công
Cavco Industries Jumps 7.1% Amid Sector-Wide Selling - AlphaStreet
Why (CSBR) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Champions Oncology (NASDAQ:CSBR) Stock Crosses Above Fifty Day Moving AverageShould You Sell? - MarketBeat
Aug Decliners: How does Champions Oncology Inc compare to its peersMarket Activity Report & Growth Focused Investment Plans - baoquankhu1.vn
Aug Catalysts: What is Champions Oncology Incs debt to equity ratio2026 Macro Moves & Consistent Return Investment Signals - baoquankhu1.vn
Chipmakers Recap: Should I average down on ACMR stockWeekly Profit Recap & Long-Term Growth Portfolio Plans - baoquankhu1.vn
Comedian Michael Kosta Headlines Karmanos Comedy Champions - PR Newswire
CSBR Should I Buy - Intellectia AI
Champions Oncology to present eight studies at AACR meeting By Investing.com - Investing.com Australia
Champions Oncology to present eight studies at AACR meeting - Investing.com
Champions Oncology to Present New Data on Predicting Response and Resistance at AACR 2026 - ACCESS Newswire
Eight cancer studies from Champions Oncology focus on drug response, resistance - Stock Titan
Bond Watch: Can Champions Oncology Inc weather a recessionWeekly Trading Summary & Verified Technical Signals - baoquankhu1.vn
Patient Derived Xenograft (PDX) Models Market is estimated - openPR.com
How does Champions Oncology Inc compare to its peers2026 Biggest Moves & Growth-Oriented Investment Plans - baoquankhu1.vn
Fennec Pharmaceuticals Inc. (FENC) stock price, news, quote and history - Yahoo Finance UK
CSBR Forecast, Price Target & Analyst Ratings | CHAMPIONS ONCOLOGY INC (NASDAQ:CSBR) - ChartMill
Understanding Momentum Shifts in (CSBR) - Stock Traders Daily
Performance Recap: What is Champions Oncology Incs debt to equity ratioMarket Risk Summary & Community Trade Idea Sharing - baoquankhu1.vn
CSBR Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Champions Oncology, Inc.Common Stock (NQ: CSBR - The Chronicle-Journal
Market Review: How correlated is Champions Oncology Inc to the S P5002026 Setups & Long-Term Capital Growth Strategies - baoquankhu1.vn
Global Tumor Models Market Set to Soar from $2.37B in 2026 - GlobeNewswire
Datavault AI Inc. (NASDAQ: DVLT) and Demora Foundation Execute Technology Integration Agreement to Power the K-Entertainment & K-Wave Global Platform - STT Info
CSBR PE Ratio & Valuation, Is CSBR Overvalued - Intellectia AI
Datavault AI Returns a Second Time for Exclusive Investor Forum at Mar-a-Lago - NTB Kommunikasjon
Jenny Hammarberg Appointed CEO of LawlineBringing Legal Expertise to Users Through AI - STT Info
Datavault AI and Coppercore Inc. Announce Tokenization of High-Grade Copper Resources into Coppercoin(TM) - STT Info
Champions Oncology appoints Brian Alexander to board By Investing.com - Investing.com Australia
The World's First Agentic CMS Just Got Smarter: Kontent.ai Launches Expert Agents - Via Ritzau
Risk Off: How does Champions Oncology Inc compare to its peersLayoff News & Technical Pattern Based Buy Signals - baoquankhu1.vn
Champions Oncology Adds Director to Advance Data-Driven Strategy - TipRanks
Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology Strategy - irw-press.com
Champ appoints Dr. Brian Alexander to board after Dr. Philip Breitfeld resignation - TradingView
Brian Alexander joins Champions Oncology (NASDAQ: CSBR) board - Stock Titan
Stock Market Recap: Will Champions Oncology Inc benefit from geopolitical trends2026 Bull vs Bear & Safe Entry Momentum Tips - baoquankhu1.vn
Champions Oncology appoints Brian Alexander to board - Investing.com
Champions Oncology taps data-focused cancer doctor for board seat - Stock Titan
Mandela Dollar ("MUSD") Announced to Promote Mandela's Legacy of Financial Inclusion for Underserved Communities Across the World - STT Info
Safe Staffing Requires New Models of Care, Not Just More Clinicians, Says Global Taskforce - STT Info
Champions Oncology, Inc. Appoints Brian Alexander to Board of Directors - marketscreener.com
MAIA PE Ratio & Valuation, Is MAIA Overvalued - Intellectia AI
Targets Report: Is Vinci Partners Investments Ltd a good ESG investment2026 Reactions & Verified Trade Idea Suggestions - baoquankhu1.vn
New Highs: Is Champions Oncology Inc showing insider buying2026 Fundamental Recap & Risk Controlled Daily Plans - baoquankhu1.vn
Valuation Update: Is Champions Oncology Inc stock trending bullishWeekly Stock Report & Risk Controlled Daily Plans - baoquankhu1.vn
Avoiding Lag: Real-Time Signals in (CSBR) Movement - Stock Traders Daily
Champions Oncology outlines full year revenue growth and positive adjusted EBITDA targets amid early traction in data business - MSN
IPO Launch: Is FOXXW stock undervalued right nowTrade Risk Assessment & Risk Controlled Daily Trade Plans - baoquankhu1.vn
Strengthening Preclinical Packages for FDA Radiopharmaceutical Approval - PharmTech.com
Nasdaq Moves: What is the Moat Score of Champions Oncology Inc2026 Price Action Summary & Verified Chart Pattern Signals - baoquankhu1.vn
Trading Action: How does Champions Oncology Inc score in quality rankingsEarnings Risk Summary & Free Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Nasdaq Moves: How correlated is Champions Oncology Inc to the S P5002026 Gainers & Low Volatility Stock Recommendations - baoquankhu1.vn
Guidance Update: Will Champions Oncology Inc benefit from geopolitical trends2026 Snapshot & Verified Entry Point Signals - baoquankhu1.vn
0.14%
0.48%
大文字化:
|
ボリューム (24 時間):